
Wilbe Capital
AI Verified
United Kingdom
Venture Capital
United Kingdom, London
2022
Criteria | Requirements | Match |
---|---|---|
Regions | North America, Northern Europe, Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Seed, Pre-Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
Wilbe Capital serves as a comprehensive ecosystem designed specifically for scientific leaders looking to transition into entrepreneurship. Unlike traditional venture firms, Wilbe has pioneered a full-stack approach that combines financial backing with practical resources tailored to the unique challenges scientists face when commercializing research. Their integrated model addresses the common disconnect between scientific expertise and business acumen that often hinders deep-tech innovation.
The firm's investment philosophy centers on identifying and nurturing scientist-entrepreneurs with transformative ideas across biotechnology, materials science, clean energy, and other frontier technology sectors. Wilbe's portfolio typically includes companies leveraging breakthrough scientific discoveries with significant commercial potential, particularly those addressing complex global challenges. Their funding approach accommodates the longer development timelines and capital requirements characteristic of science-based ventures.
Beyond capital, Wilbe provides members with an exceptional suite of resources including dedicated laboratory facilities, entrepreneurial training programs, and specialized mentorship from experienced science-business leaders. This comprehensive support system helps technical founders navigate critical early-stage challenges such as prototype development, intellectual property strategy, and market validation. Their advocacy work also aims to bridge gaps in the innovation ecosystem that disproportionately affect scientist-led startups.
The Wilbe community extends its reach through various digital platforms, including their YouTube channel and X (formerly Twitter) presence, where they share insights on science commercialization, founder stories, and industry trends. Their collaborative approach fosters connections between academic institutions, industry partners, and investment networks to create a robust support system for emerging science-based companies. Prospective members and partners can explore opportunities to engage with Wilbe's innovation ecosystem through their website or by reaching out directly via email.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
Wilbe Capital maintains its global headquarters in United Kingdom, serving as the strategic center for its operations. The company's primary corporate offices are located at United Kingdom, London.
Wilbe Capital focuses its investment activities on companies operating in the following stages: Seed, Pre-Seed. Wilbe Capital provides strategic capital and expertise to support promising businesses at these critical phases of development.
Wilbe Capital maintains a strategic global investment presence, actively seeking opportunities across the following key regions: North America, Northern Europe, Western Europe.
Wilbe Capital was established in 2022, marking the beginning of its journey as an investment firm.
Wilbe Capital is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.